Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
02/2012
02/16/2012US20120040385 Coagulogen raw material, process for producing the same, and method and apparatus for measuring physiologically active substance of biological origin using the same
02/16/2012US20120040384 Lyophilised dabigatran
02/16/2012US20120040383 Methods and Kits Relating To Metabolite Biomarkers For Colorectal Cancer
02/16/2012US20120040380 Optically-detectable enzyme substrates and their method of use
02/16/2012US20120040370 Systems and methods for rapidly changing the solution environment around sensors
02/16/2012US20120040369 On-board control detection
02/16/2012US20120040368 Mutated voltage-gated sodium channel nav alpha subunit for identification of modulators
02/16/2012US20120040367 Construct system and uses therefor
02/16/2012US20120040366 Compositions, methods and uses for disease diagnosis
02/16/2012US20120040365 New competence stimulating peptide
02/16/2012US20120040364 Compensator for multiple surface imaging
02/16/2012US20120040363 Method for enriching a prokaryotic dna
02/16/2012US20120040362 Multipotent Lymphohematopoietic Progenitor Cells
02/16/2012US20120040361 Methods and compositions for detection of lethal system and uses thereof
02/16/2012US20120040360 Compositions, methods and kits to detect dicer gene mutations
02/16/2012US20120040359 Endonuclease-Enhanced Helicase-Dependent Amplification
02/16/2012US20120040358 Biomarker Panel for Diagnosis and Prediction of Graft Rejection
02/16/2012US20120040357 Compositions, methods and kits to detect dicer gene mutations
02/16/2012US20120040356 Methods for Detecting Oncofetal Fibronectin
02/16/2012US20120040355 Ykl-40 as a marker for selection of treatment and monitoring of a disease
02/16/2012US20120040354 Methods of classifying the severity of diseases or disorders
02/16/2012US20120040353 Detection and quantification of microRNAs in the circulation and the use of circulating microRNAs as biomarkers in cancer
02/16/2012US20120040352 Primers, probes and methods for nucleic acid amplification
02/16/2012US20120040351 Genetic markers of schizophrenia
02/16/2012US20120040350 Genetic markers of schizophrenia
02/16/2012US20120040349 Method for detecting nucleic acids
02/16/2012US20120040348 Methods for nucleic acid quantification
02/16/2012US20120040347 Polymorphism in CYP3A4 Gene Affecting Drug Metabolizing and Uses Thereof
02/16/2012US20120040346 Method of Determining Chemotherapy of Metastatic Tumor by Assaying DPD Gene Expression in Primary Tumors
02/16/2012US20120040345 2-Nitrobenzyl-Modified Ribonucleotides
02/16/2012US20120040344 PREDICTIVE USE OF CpG METHYLATION
02/16/2012US20120040343 Detecting and Sorting Methylated DNA Using a Synthetic Nanopore
02/16/2012US20120040342 Genetic Indicators Of Weight Loss
02/16/2012US20120040341 Method for the Detection and Diagnosis of Cancer Involving Primers and Probes for the Specific Detection of the MAGE-A3-Marker
02/16/2012US20120040340 Nucleotide analogs
02/16/2012US20120040339 Imaging Glyphosate in Plant Tissue
02/16/2012US20120040338 RBM3 in Testicular Cancer Diagnostics and Prognostics
02/16/2012US20120040337 Conformational Epitope Initiated Signal Amplification
02/16/2012US20120040336 Lateral Flow Assays for Non-Diagnostic Analytes
02/16/2012US20120040335 Identification of Porcine Reproductive and Respiratory Syndrome Virus
02/16/2012US20120040334 Diagnostic Transcript and Splice Patterns of HPV16 in Different Cervical Lesions
02/16/2012US20120040333 Methods to Distinguish Different Disaccharide Products after Digestion with Heparinases
02/16/2012US20120040332 Assay for detection of adrenal tumour
02/16/2012US20120040101 Techniques to improve polyurethane membranes for implantable glucose sensors
02/16/2012US20120040021 Methods and compositions for the treatment of cancer
02/16/2012US20120040017 Genetic test for liver copper accumulation in dogs and low copper pet diet
02/16/2012US20120039993 Detection of Gene Expression
02/16/2012US20120039986 Compositions and methods for sirna inhibition of angiopoietin 1 and 2 and their receptor tie2
02/16/2012US20120039943 Factors
02/16/2012US20120039936 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
02/16/2012US20120039924 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
02/16/2012US20120039921 Poultry viral materials and methods related thereto
02/16/2012US20120039914 Methods and compositions for using mhc class ii invariant chain polypeptides as a receptor for macrophage migration inhibitory factor
02/16/2012US20120039912 Rspondin-3 inhibition in bone disorders
02/16/2012US20120039911 Cd93 or use of soluble fragment thereof
02/16/2012US20120039900 Biomarkers predictive of the responsiveness to tnfalpha inhibitors in autoimmune disorders
02/16/2012US20120039899 Anti-Hemagglutinin Antibody Compositions And Methods Of Use Thereof
02/16/2012US20120039898 Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
02/16/2012US20120039894 Identification of therapeutic agents for hiv infection
02/16/2012US20120039893 Mutant smoothened and methods of using the same
02/16/2012US20120039889 Methods of diagnosing and treating prostate cancer characterized by ndrg1-erg fusion
02/16/2012US20120039887 Compositions and methods for diagnosing prostate cancer based on detection of slc45a3-elk4 fusion transcript
02/16/2012US20120039875 Diagnostic and therapeutic methods and compositions involving pten and breast cancer
02/16/2012US20120039868 Biomarkers for Graft Rejection
02/16/2012US20120039867 Immune System Function in Conditions Characterized by Elevated Double Strand Breaks
02/16/2012US20120039864 Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
02/16/2012US20120039854 Nanoparticle Targeted Drug Delivery to the Lungs Using Extra-Testicular Sertoli Cells
02/16/2012US20120039851 Use of androgens for vascular regeneration and endothelial repair
02/16/2012US20120039812 Genes associated with posttraumatic-stress disorder (ptsd)
02/16/2012US20120039811 Markers for cancer detection
02/16/2012US20120039810 Aptamer-containing compositions and methods for targeting e-selectin
02/16/2012US20120039808 Brain Tumor Stem Cell Differentiation Promoter, and Therapeutic Agent for Brain Tumor
02/16/2012US20120039805 Therapeutics And Methods For Treating Neoplastic Diseases Comprising Determining The Level Of Caveolin-1 And/Or Caveolin-2 In A Stromal Cell Sample
02/16/2012US20120037514 Enzymatic Electrochemical Biosensor
02/16/2012US20120037513 Diagnostic multi-layer dry phase test strip with integrated biosensors ("electrostrip")
02/16/2012DE102010046284B3 Apparatus, useful for preparing food samples for microbiological examination, comprises hermetically closable trained transport container having a closure means, with which the container is closable after loading with sample bag
02/16/2012DE102010037001A1 Neue Biosensoren und deren Verwendung New Biosensors and their use
02/16/2012DE102010013114B4 Prädiagnostisches Sicherheitssystem Prädiagnostisches security system
02/16/2012DE102004045186B9 Liposomen, die die intrazelluläre Penetration von Wirkstoffen stimulieren, deren Verwendung zur Herstellung von topischen pharmazeutischen bzw. kosmetischen Zusammensetzungen, die diese Liposomen enthalten sowie ein Screening-Verfahren zum Auffinden von Substanzen zur Stimulierung der intrazellulären Penetration Liposomes, which stimulate the intracellular penetration of active substances, their use for the preparation of topical pharmaceutical and cosmetic compositions containing these liposomes as well as a screening method for finding substances for stimulating the intracellular penetration
02/16/2012CA2841940A1 Method for identifying antimicrobial compounds and determining antibiotic sensitivity
02/16/2012CA2810856A1 Compositions and methods for quantifying a nucleic acid sequence in a sample
02/16/2012CA2807935A1 Method of producing pancreatic hormone-producing cells
02/16/2012CA2807926A1 Method for diagnosing neurodegenerative diseases
02/16/2012CA2807923A1 Method and kit for the diagnosis and/or prognosis of tolerance in liver transplantation
02/16/2012CA2807918A1 New markers for the epithelial and proliferative or mesenchymal invasive phenotype of human neoplasias
02/16/2012CA2807133A1 Method for measuring glycated hemoglobin
02/16/2012CA2806261A1 Method for measuring glycated hemoglobin
02/16/2012CA2805803A1 Compositions and methods comprising sequences having hydroxyphenylpyruvate dioxygenase (hppd) activity
02/16/2012CA2804857A1 Pancreatic cancer biomarkers and uses thereof
02/16/2012CA2804424A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
02/16/2012CA2804416A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
02/15/2012EP2418490A1 Tumor marker and use thereof
02/15/2012EP2418489A1 Marker for diagnosing lung cancer and colorectal cancer containing glutaredoxin 3 as active ingredient and kit for diagnosing lung cancer and colorectal cancer using the same
02/15/2012EP2418484A2 Production process of gender-specific serum and biomarker using the serum
02/15/2012EP2418291A1 A CD26 (DPP-4) inhibitor for use in treatment of HCV infection
02/15/2012EP2418290A1 Methods for Regulation of Stem Cells
02/15/2012EP2418289A1 Method of distinguishing genotypes
02/15/2012EP2418288A1 Method and kit for the diagnosis and prognosis of tolerance in liver transplantation employing liver tissue
02/15/2012EP2418287A2 Nucleic acid amplification primers for PCR-based clonality studies of the TCR-beta gene
02/15/2012EP2418286A1 Improved method for isothermal amplification of nucleic acids